Correlation of Integrin Β3 Mrna and Vascular Endothelial Growth Factor Protein Expression Profiles with the Clinicopathological Features and Prognosis of Gastric Carcinoma

Shu-Guang Li,Zai-Yuan Ye,Zhong-Sheng Zhao,Hou-Quan Tao,Yuan-Yu Wang,Chun-Yu Niu
DOI: https://doi.org/10.3748/wjg.14.421
2008-01-01
Abstract:AIM: To investigate integrin beta 3 mRNA and vascular endothelial growth factor (VEGF) protein expression in gastric carcinoma, and its correlation with microvascular density, growth-pattern, invasion, metastasis and prognosis.METHODS: In situ hybridization (ISH) of integrin beta 3 mRNA and immunohistochemistry of VEGF and CD34 protein were performed on samples from 118 patients with gastric cancer.RESULTS: The positive rate of integrin beta 3 mRNA in non-tumor gastric mucosa (20%) was significantly lower than that of the gastric cancer tissue (52.5%, X-2 = 10.20, P < 0.01). In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of integrin beta 3 mRNA were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the positive expression rates of VEGF protein. were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. In patients of infiltrating type, stage T-3-T-4, vessel invasion, lymphatic metastasis, hepatic or peritoneal metastasis, the mean MVD were significantly higher than those in patients of expanding type (P < 0.01), stage T-1-T-2 (P < 0.01), non-vessel invasion (P < 0.01), without lymphatic metastasis (P < 0.01), without hepatic and peritoneal metastasis (P < 0.01), respectively. It was found that the positive expression rate of integrin beta 3 mRNA was positively related to that of VEGF protein (P < 0.01) and MVD (P < 0.05), meanwhile the positive expression rate of VEGF protein was positively related to MVD (P < 0.05); The mean survival period in patients with positive expression of integrin beta 3 mRNA and VEGF, and MVD >= 54.9/mm(2) was significantly shorter than that in patients with negative expression of integrin beta 3 mRNA (P < 0.05) and VEGF (P < 0.01), and MVD < 54.9/mm(2) (P < 0.01). Five-year survival rate in patients with positive expression of integrin beta 3 mRNA and VEGF, and MVD >= 54.9/mm(2) was significantly lower than those with negative expression of integrin beta 3 mRNA (P < 0.05), VEGF (P < 0.05), and MVD < 54.9/mm(2) (P < 0.01).CONCLUSION: Integrin beta 3 and VEGF expression can synergistically enhance tumor angiogenesis, and may play a crucial role in invasion and metastasis of gastric carcinoma. Therefore, they may be prognostic biomarkers and novel molecular therapeutic targets. (c) 2008 WJG. All rights reserved.
What problem does this paper attempt to address?